Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for prevention of severe oral mucositis during adjuvant chemoradiotherapy in advanced head and neck cancer
2004-002016-28Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of palifermin in stomatitis, sponsored by Amgen. Started Oct 2004; status: completed.
02
Drugs
palifermin
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2004-002016-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002016-28.